2025 first_quarter Filing
Q1Income
$40K
Filed
April 16, 2025
Lobbying Activities
Health IssuesView all
Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regard the International Pricing Index (IPI) Model, which would import single-payer government run price controls that limit innovation and patient access to life saving therapies. Support for PBM reform. HR 2214 -- "DRUG Act" HR 1492 -- "To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program."
Contacted:Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (1)
MATTHEW MCGINLEY